Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSPHENYTOIN for Encephalopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where FOSPHENYTOIN was used for Encephalopathy.

Most Reported Side Effects for FOSPHENYTOIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 406 29.5% 47 259
Off label use 164 11.9% 18 77
Status epilepticus 82 6.0% 10 53
Multiple-drug resistance 77 5.6% 3 11
Cardiac arrest 72 5.2% 51 28
Seizure 70 5.1% 8 36
Drug ineffective for unapproved indication 63 4.6% 10 44
Hypotension 56 4.1% 9 24
Toxicity to various agents 53 3.9% 9 35
Bradycardia 39 2.8% 14 12
Treatment failure 37 2.7% 2 19
Product use in unapproved indication 36 2.6% 11 15
Product use issue 36 2.6% 4 15
Hepatic function abnormal 35 2.5% 6 28
Drug interaction 34 2.5% 4 20

Other Indications for FOSPHENYTOIN

Status epilepticus (385) Seizure (297) Epilepsy (116) Generalised tonic-clonic seizure (71) Product used for unknown indication (64) Partial seizures (33) Trigeminal neuralgia (29) New onset refractory status epilepticus (28) Febrile infection-related epilepsy syndrome (26) Epilepsia partialis continua (16)

Other Drugs Used for Encephalopathy

RIFAXIMIN (82) METHYLPREDNISOLONE (68) HUMAN IMMUNOGLOBULIN G (67) LEVETIRACETAM (64) LACTULOSE (45) VIGABATRIN (33) RITUXIMAB (21) DEXAMETHASONE (20) RISPERIDONE (17) DIAZEPAM (15)

Related Pages

FOSPHENYTOIN Full Profile All Encephalopathy Drugs FOSPHENYTOIN Demographics FOSPHENYTOIN Timeline